Johnson & Johnson voluntarily recalled approximately 4.8 million packages of Children's Benadryl and Motrin due to "insufficiencies" in the manufacturing process. Spokeswoman for the company, Bonnie Jacobs, stated that 4 million packages of the allergy tablet Benadryl and 800,000 bottles of junior-strength Motrin caplets are recalled.
The good news is they are stating that the medicines are not dangerous but according to the news release "after a review, conducted as part of McNeil’s comprehensive action plan, revealed insufficiencies in the development of the manufacturing process."
The iconic Johnson & Johnson has been dealing with serious quality control issues lately. McNeil Consumer Healthcare, the Johnson & Johnson division, has announced eight recalls since September 2009.
The McNeil unit says the recall includes all Junior Strength Motrin Caplets, 24 count, distributed in the U.S. It also says there is no sign the caplets don’t meet quality standards and that there have been no reports of adverse effects of taking the medication.
According to the company website, consumers do not have to take action. The recalls are at the "wholesale and retail level."
Products being recalled are Children’s Benadryl Allergy Fastmelt Tablets, cherry flavor, with a code number of 50580-347-18; Children’s Benadryl Allergy Fastmelt Tablets, grape flavor, code number 50580-348-18; and Junior Strength Motrin Caplets, 24 count, code number 50580-498-24.
Johnson and Johnson says consumers with questions should call 888-222-6036 begin_of_the_skype_highlighting 888-222-6036 end_of_the_skype_highlighting Monday through Friday between 8 a.m. and 8 p.m. and Saturday and Sunday between 9 a.m. and 5 p.m. EST.
Comments